Advertisement
Mayo Clinic Proceedings Home

Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community

Published:September 06, 2015DOI:https://doi.org/10.1016/j.mayocp.2015.07.016

      Abstract

      Objective

      To determine the variation in kidney stone composition and its association with risk factors and recurrence among first-time stone formers in the general population.

      Patients and Methods

      Medical records were manually reviewed and validated for symptomatic kidney stone episodes among Olmsted County, Minnesota, residents from January 1, 1984, through December 31, 2012. Clinical and laboratory characteristics and the risk of symptomatic recurrence were compared between stone compositions.

      Results

      There were 2961 validated first-time symptomatic kidney stone formers. Stone composition analysis was obtained in 1508 (51%) at the first episode. Stone formers were divided into the following mutually exclusive groups: any brushite (0.9%), any struvite (0.9%), any uric acid (4.8%), and majority calcium oxalate (76%) or majority hydroxyapatite (18%). Stone composition varied with clinical characteristics. A multivariable model had a 69% probability of correctly estimating stone composition but assuming calcium oxalate monohydrate stone was correct 65% of the time. Symptomatic recurrence at 10 years was approximately 50% for brushite, struvite, and uric acid but approximately 30% for calcium oxalate and hydroxyapatite stones (P<.001). Recurrence was similar across different proportions of calcium oxalate and hydroxyapatite (P for trend=.10). However, among calcium oxalate stones, 10-year recurrence rate ranged from 38% for 100% calcium oxalate dihydrate to 26% for 100% calcium oxalate monohydrate (P for trend=.007).

      Conclusion

      Calcium stones are more common (93.5% of stone formers) than has been previously reported. Although clinical and laboratory factors associate with the stone composition, they are of limited utility for estimating stone composition. Rarer stone compositions are more likely to recur.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Scales Jr., C.D.
        • Smith A.C.
        • Hanley J.M.
        • Saigal C.S.
        Prevalence of kidney stones in the United States.
        Eur Urol. 2012; 62: 160-165
        • El-Zoghby Z.M.
        • Lieske J.C.
        • Foley R.N.
        • et al.
        Urolithiasis and the risk of ESRD.
        Clin J Am Soc Nephrol. 2012; 7: 1409-1415
        • Pak C.Y.
        • Poindexter J.R.
        • Adams-Huet B.
        • Pearle M.S.
        Predictive value of kidney stone composition in the detection of metabolic abnormalities.
        Am J Med. 2003; 115: 26-32
        • Kourambas J.
        • Aslan P.
        • Teh C.L.
        • Mathias B.J.
        • Preminger G.
        Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis.
        J Endourol. 2001; 15: 181-186
        • Kasidas G.P.
        • Samuell C.T.
        • Weir T.B.
        Renal stone analysis: why and how?.
        Ann Clin Biochem. 2004; 41: 91-97
        • Daudon M.
        Rev Med Suisse Romande. 2004; 124 ([in French]): 445-453
        • Skolarikos A.
        • Straub M.
        • Knoll T.
        • et al.
        Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
        Eur Urol. 2015; 67: 750-763
        • Pearle M.S.
        • Goldfarb D.S.
        • Assimos D.G.
        • et al.
        Medical management of kidney stones: AUA guideline.
        J Urol. 2014; 192: 316-324
        • Qaseem A.
        • Dallas P.
        • Forciea M.A.
        • Starkey M.
        • Denberg T.D.
        Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.
        Ann Intern Med. 2014; 161: 659-667
        • Moe O.W.
        Kidney stones: pathophysiology and medical management.
        Lancet. 2006; 367: 333-344
        • Herring L.C.
        Observations on the analysis of ten thousand urinary calculus.
        J Urol. 1962; 88: 545-555
        • Mandel N.S.
        • Mandel G.S.
        Urinary tract stone disease in the United States veteran population, I: geographical frequency of occurrence.
        J Urol. 1989; 142: 1513-1515
        • Rocca W.A.
        • Yawn B.P.
        • St Sauver J.L.
        • Grossardt B.R.
        • Melton III, L.J.
        History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.
        Mayo Clin Proc. 2012; 87: 1202-1213
        • Rule A.D.
        • Lieske J.C.
        • Li X.
        • Melton 3rd, L.J.
        • Krambeck A.E.
        • Bergstralh E.J.
        The ROKS Nomogram for Predicting a Second Symptomatic Stone Episode.
        J Am Soc Nephrol. 2014; 25: 2878-2886
        • Lieske J.C.
        • Rule A.D.
        • Krambeck A.E.
        • et al.
        Stone composition as a function of age and sex.
        Clin J Am Soc Nephrol. 2014; 9: 2141-2146
        • Taylor E.N.
        • Curhan G.C.
        Oxalate intake and the risk for nephrolithiasis.
        J Am Soc Nephrol. 2007; 18: 2198-2204
        • Lee T.T.
        • Elkoushy M.A.
        • Andonian S.
        Are stone analysis results different with repeated sampling?.
        Can Urol Assoc J. 2014; 8: E317-E322
        • Daudon M.
        • Donsimoni R.
        • Hennequin C.
        • et al.
        Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy.
        Urol Res. 1995; 23: 319-326
        • Gault M.H.
        • Chafe L.
        Relationship of frequency, age, sex, stone weight and composition in 15,624 stones: comparison of resutls for 1980 to 1983 and 1995 to 1998.
        J Urol. 2000; 164: 302-307
        • Pierratos A.E.
        • Khalaff H.
        • Cheng P.T.
        • Psihramis K.
        • Jewett M.A.
        Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones.
        J Urol. 1994; 151: 571-574
        • Daudon M.
        • Bader C.A.
        • Jungers P.
        Urinary calculi: review of classification methods and correlations with etiology.
        Scanning Microsc. 1993; 7: 1081-1104
        • Duan X.
        • Qu M.
        • Wang J.
        • et al.
        Differentiation of calcium oxalate monohydrate and calcium oxalate dihydrate stones using quantitative morphological information from micro-computerized and clinical computerized tomography.
        J Urol. 2013; 189: 2350-2356
        • Maalouf N.M.
        • Cameron M.A.
        • Moe O.W.
        • Sakhaee K.
        Novel insights into the pathogenesis of uric acid nephrolithiasis.
        Curr Opin Nephrol Hypertens. 2004; 13: 181-189
        • Khatchadourian J.
        • Preminger G.M.
        • Whitson P.A.
        • Adams-Huet B.
        • Pak C.Y.
        Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation.
        J Urol. 1995; 154: 1665-1669
        • Abate N.
        • Chandalia M.
        • Cabo-Chan Jr., A.V.
        • Moe O.W.
        • Sakhaee K.
        The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
        Kidney Int. 2004; 65: 386-392
        • Krambeck A.E.
        • Lieske J.C.
        • Li X.
        • Bergstralh E.J.
        • Melton III, L.J.
        • Rule A.D.
        Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population.
        J Urol. 2013; 189: 158-164
        • Sakhaee K.
        • Adams-Huet B.
        • Moe O.W.
        • Pak C.Y.
        Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
        Kidney Int. 2002; 62: 971-979
        • Shekarriz B.
        • Stoller M.L.
        Uric acid nephrolithiasis: current concepts and controversies.
        J Urol. 2002; 168: 1307-1314
        • Cirillo M.
        • Laurenzi M.
        Elevated blood pressure and positive history of kidney stones: results from a population-based study.
        J Hypertens Suppl. 1988; 6: S485-S486
        • Daudon M.
        • Dore J.C.
        • Jungers P.
        • Lacour B.
        Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach.
        Urol Res. 2004; 32: 241-247
        • Krambeck A.E.
        • Handa S.E.
        • Evan A.P.
        • Lingeman J.E.
        Profile of the brushite stone former.
        J Urol. 2010; 184: 1367-1371
        • Kenny J.E.
        • Goldfarb D.S.
        Update on the pathophysiology and management of uric acid renal stones.
        Curr Rheumatol Rep. 2010; 12: 125-129
        • Selby M.G.
        • Vrtiska T.J.
        • Krambeck A.E.
        • et al.
        Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events.
        Urology. 2015; 85: 45-50
        • Coe F.L.
        • Parks J.H.
        Cystine stones.
        in: Nephrolithiasis: Pathogenesis and Treatment. 2nd ed. Year Book Medical Publishers, Chicago, IL1988: 269-275
        • Mandel N.
        • Mandel I.
        • Fryjoff K.
        • Rejniak T.
        • Mandel G.
        Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes.
        J Urol. 2003; 169: 2026-2029
        • Leng S.
        • Shiung M.
        • Ai S.
        • et al.
        Feasibility of discriminating uric acid from non-uric acid renal stones using consecutive spatially registered low- and high-energy scans obtained on a conventional CT scanner.
        AJR Am J Roentgenol. 2015; 204: 92-97
        • Liu Y.
        • Qu M.
        • Carter R.E.
        • et al.
        Differentiating calcium oxalate and hydroxyapatite stones in vivo using dual-energy CT and urine supersaturation and pH values.
        Acad Radiol. 2013; 20: 1521-1525